✦ LIBER ✦

Effects of interleukin-3 following chemotherapy of non-Hodgkin's lymphoma. A prospective, controlled phase I/II study.

✍ Scribed by D. J. Hovgaard; N. I. Nissen

Book ID: 114792017
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 681 KB
Volume: 54
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1995.tb01772.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic and pharmacodynamic stud

Pharmacokinetic and pharmacodynamic studies of subcutaneously administered recombinant human interleukin-3 following chemotherapy for non-Hodgkin's lymphoma

✍ D. J. Hovgaard; B. T. Mortensen; N. I. Nissen 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

A randomized study of radiotherapy versu

A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-hodgkin's lymphomas

✍ Nis I. Nissen; Jens Ersbøll; Hanne Sand Hansen; Sven Walbom-Jørgensen; Jens Pede 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

In a randomized, prospective trial from 1974-1978, 73 patients with non-Hodgkin's lymphomas in clinical Stage I or II were treated with extended field radiotherapy alone (RT) or RT plus adjuvant chemotherapy with vincristine, streptonigrin, cyclophosphamide and prednisone (RT + CT). With a median fo

Adjubant chop chemotherapy following rad

Adjubant chop chemotherapy following radiotherapy in stage I low and intermediate grade non-hodgkin's lymphoma: Results of a prospective randomized study

✍ George Varsos; Joachlm Yahalom; Zvi Fuks; Jane Myers; Bayard Clarkson; David Str 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A multicenter phase II study of darinapa

A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma

✍ Peter J. Hosein; Michael D. Craig; Martin S. Tallman; Ralph V. Boccia; Brian L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

ABVD: doxorubicin,

Phase II study of ifosfamide, etoposide,

Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma

✍ Seon-Kyeong Kim,Moo-Kon Song,Joo Seop Chung… 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 174 KB

43 EFFICACY OF LOW-DOSE INVOLVED-FIELD R

43 EFFICACY OF LOW-DOSE INVOLVED-FIELD RADIOTHERAPY FOLLOWING 3-4 CYCLES OF CHEMOTHERAPY FOR PATIENTS WITH STAGE I-II AGGRESSIVE NON-HODGKIN'S LYMPHOMA

✍ Gauthier, I.; Després, P.; Roy, I. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 31 KB